Regeneron Pharmaceuticals
REGN
#273
Rank
S$103.88 B
Marketcap
S$982.62
Share price
1.18%
Change (1 day)
-0.48%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): S$6.76 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$14.34 Billion. , an increase over its 2024 earnings that were of S$6.10 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 S$6.68 B9.43%
2024 S$6.10 B13.83%
2023 S$5.36 B-13.57%
2022 S$6.20 B-47.9%
2021 S$11.91 B144.75%
2020 S$4.86 B56.86%
2019 S$3.10 B-4.87%
2018 S$3.26 B22.86%
2017 S$2.65 B56.3%
2016 S$1.69 B8.55%
2015 S$1.56 B54.53%
2014 S$1.01 B11.14%
2013 S$0.91 B72.13%
2012 S$0.52 B-285.93%
2011 -S$0.29 Billion121.73%
2010 -S$0.13 Billion37.18%
2009 -S$93.66 Million-14.6%
2008 -S$0.11 Billion-25.02%
2007 -S$0.15 Billion6.32%
2006 -S$0.14 Billion-186.52%
2005 S$0.15 B2103.7%
2004 S$7.21 M-105.66%
2003 -S$0.13 Billion-18.18%
2002 -S$0.16 Billion42.33%
2001 -S$0.11 Billion129.35%
2000 -S$47.75 Million51.87%
1999 -S$31.45 Million92.19%
1998 -S$16.36 Million66.23%
1997 -S$9.85 Million-55.49%
1996 -S$22.12 Million103.53%
1995 -S$10.87 Million-70.89%
1994 -S$37.32 Million-26.08%
1993 -S$50.49 Million114.67%
1992 -S$23.52 Million196.77%
1991 -S$7.93 Million87.88%
1990 -S$4.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.40 B 519.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.89 B 212.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
S$10.53 B 57.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$11.63 B 73.98%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$2.43 B-63.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA